SOPHiA GENETICS (SOPH) Non-Current Deffered Revenue (2020 - 2021)
SOPHiA GENETICS (SOPH) posted Non-Current Deffered Revenue of $134000.0 for Q3 2021, down 2.9% sequentially from $138000.0 in Q2 2021.
SOPHiA GENETICS (SOPH) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
SOPHiA GENETICS has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $134000.0 in Q3 2021.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $134000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $134000.0 (changed N/A YoY) and the FY2020 annual result came in at $142000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue fell to $134000.0 in Q3 2021 per SOPH's latest filing, from $138000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $142000.0 in Q4 2020 and troughed at $134000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 5.02 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 9.68 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 6.75 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 37,000.00 |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | SOPHiA GENETICS | 553.79 Mn | 446.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 134,000.00 |
| Jun 30, 2021 | 138,000.00 |
| Dec 31, 2020 | 142,000.00 |